0002014918-24-000001.txt : 20240311 0002014918-24-000001.hdr.sgml : 20240311 20240308191654 ACCESSION NUMBER: 0002014918-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240308 EFFECTIVENESS DATE: 20240311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurock Pharmaceuticals Inc. CENTRAL INDEX KEY: 0002014918 ORGANIZATION NAME: IRS NUMBER: 921276111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-507160 FILM NUMBER: 24736178 BUSINESS ADDRESS: STREET 1: 302 CARNEGIE CENTER, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 908-926-3116 MAIL ADDRESS: STREET 1: 302 CARNEGIE CENTER, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 D 1 primary_doc.xml X0708 D LIVE 0002014918 Neurock Pharmaceuticals Inc. 302 CARNEGIE CENTER, SUITE 100 PRINCETON NJ NEW JERSEY 08540 908-926-3116 DELAWARE None None Corporation true 2022 Lei Cai 302 CARNEGIE CENTER, SUITE 100 Princeton NJ NEW JERSEY 08540 Executive Officer Qingxi Wang 302 CARNEGIE CENTER, SUITE 100 Princeton NJ NEW JERSEY 08540 Director Haixing Wang 302 CARNEGIE CENTER, SUITE 100 Princeton NJ NEW JERSEY 08540 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2024-02-29 false true false 0 10000000 10000000 0 false 1 0 0 0 false Neurock Pharmaceuticals Inc. /s/ Lei Cai Lei Cai CEO 2024-03-08